CENCORAPriority claimed from 16/08/2022; Application No. : MU/M/2022/36519 ;Mauritius (Class 44)

The trademark application number 5806971 is owned by AmerisourceBergen Corporation.

Trademark application number 5806971 is filed under Class 44, which relates to the specified goods and services.

The trademark agent associated with application number 5806971 is LALL & SETHI.

Yes, trademark application number 5806971 was published in Journal No. 2117.

Trademark application number 5806971 relates to "Medical analysis services; Medical analysis services, namely, analyzing and reporting in the field of human disease treatment; providing a secured-access internet website for medical professionals and medical patients featuring medical information and analysis of patient data in the field of oncology care practices, namely, the specific diagnosis, line of therapy, stage of disease and regimen; providing clinical and home health care services, namely, providing information relating to therapeutic properties of pharmaceuticals; providing counseling to patients in the field of administration of medications; providing a secured-access internet website for medical professionals and medical patients featuring medical information and analysis of patient data in the field of oncology care practices, namely, the specific diagnosis, line of therapy, stage of disease and regimen; providing clinical and home health care services; providing clinical and home health care services, namely, providing information relating to therapeutic properties of pharmaceuticals; providing counseling to patients in the field of administration of medications; providing medical provider and care information; providing wellness programs for disease treatment and management featuring patient-centered incentives for compliance with physician-directed educational, medication therapy, and home care programs; information services for the pharmaceutical and medical sectors; counseling services related to workplace and personnel health; healthcare services; services of information on medical substances; analysing and reporting of discussions about human disease treatment; administration and management of sophisticated pharmaceutical therapies; providing a website featuring customisable information and analysis about legislative regulatory developments in the field of healthcare; telehealth services, namely, healthcare services provided via telecommunication in the nature of remote monitoring of data indicative of the health or condition of a patient for medical treatment purposes; telehealth services, namely, providing patients with health information relating to their medical condition; beauty and health care advice services; providing nursing services to others on behalf of pharmaceutical and biotechnology companies.".